Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Black patients are more likely to require hospitalization, while Asian patients are at greater risk of dying in the hospital.
The COVID-19 pandemic has turned virtual health from a niche service into a mainstay of modern medicine. But it’s not working for everyone.
AIDS United opposes this executive order. We remain deeply concerned about its impact on ending the HIV epidemic.
Researchers studied people taking Truvada as PrEP and plan to conduct similar research on newer antiretrovirals.
Trans Latina writer, artist and organizer Sebastián Castro Niculescu explores the elements in the November web gallery on Visual AIDS.
None of the four drugs tested in WHO’s Solidarity study reduced mortality or duration of hospitalization.
Hint: It starts with three letters.
MK-8507, a long-acting NNRTI, will be tested in a weekly regimen with islatravir.
Gilead Sciences presented findings from several studies of the single-tablet antiretroviral regimen at a recent scientific meeting.
The Centers for Medicare & Medicaid Services should hit pause on a proposal.
The theme of this year’s #NLAAD is “Ending HIV Is at Your Fingertips.”
Plus: An affordable housing community for LGBT seniors in Florida sets aside units for folks with HIV.
The study asks whether certain approved therapies or late-stage investigational drugs show promise against COVID-19.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.